www.dilab.se

Interview with Mr Peter Hutchinson

 
          Mr Peter Hutchinson,
Consultant Neurosurgeon
Department of Neurosurgery
Addenbrooks hospital
Cambridge, UK
 


 

Q: How many beds and how many patients per year do you have in your ICU?
A: 21 beds. TBI admissions 140 and SAH admissions 100
 
Q: In average how many patients per year do you use Microdialysis on and what are the indications?
A: TBI 75 per year SAH 50 per year
 
Q: What year did you start to use microdialysis?
A: 1997

Q:How many patients do you estimate that you have run microdialysis on since the start?
A: Many! We are currently compiling a database.
 
Q: How are you using the Microdialysis results and what are you comparing them with?
A: We use microdialysis as part of multimodality monitoring (ICP, brain tissue
oxygen etc.) and in conjunction with functional imaging (PET).
 
Q: Are you adjusting your treatment based on the Microdialysis results?
A: Yes - we use the lactate/pyrvuate ratio (target <25) and are currently looking at which therapies are effective at reducing raised lactate/pyruvate ratios.
 
Q: How do you see the future development of Microdialysis in Neuro Intensive Care?
A: Increased use - Clinical - as a monitor to assist in the management of patients with raised ICP, contusions (targeted catheters) and to assist in titration of inotrope therapy and weaning. Research - correlation with imaging and measurement of other substances eg cytokines to increase our understanding of the pathophysiology of brain injury.